Sfoglia per AUTORE
BAVA CI
Collezione AOU San Luigi di Orbassano

  

Items : 5

2024
AOU San Luigi di Orbassano

Malucchi S; Bava CI; Valentino P; Martire S; Lo Re M; Bertolotto A; Di Sapio A;

Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2024 Aug;88:105748. doi: 10.1016/j.msard.2024.105748. Epub 2024 Jun 29.
2024
AOU San Luigi di Orbassano

Bava CI; Valentino P; Malucchi S; Bottero R; Martire S; Sapio AD; Bertolotto A;

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Sep;77:104893. doi: 10.1016/j.msard.2023.104893. Epub 2023 Jul 16.
2023
AO Cuneo
AOU San Luigi di Orbassano

Di Sapio A; Oggero A; Malentacchi M; Sperli F; Capobianco M; Martire S; Bava CI; Malucchi S; Valentino P; Bertolotto A;

sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Nov;67:104176. doi: 10.1016/j.msard.2022.104176. Epub 2022 Sep 14.
2022
AO Cuneo
AOU San Luigi di Orbassano

Bertolotto A; Capobianco MA; Bava CI; Martire S; Malucchi S; Valentino P;

Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2021 Sep;54:103090. doi: 10.1016/j.msard.2021.103090. Epub 2021 Jun 17.
2021
AOU San Luigi di Orbassano

Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A;